Nov. 21, 2024
| Today’s news and insights for medtech leaders
Aerosol deposits could accumulate on a sensor and affect oxygen delivery, the FDA said in a recall notice. Several of the ventilator models were previously recalled for separate problems.
|
Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.
|
CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.
|
An effective lifecycle management strategy is essential, as the reliability and performance of these devices can be a matter of life and death.
|
UPDATED
Philips recalled its Trilogy ventilators to fix new and previously reported problems with the machines. The company issued a mandatory software update and changed the devices’ instructions.
|
Scott Whitaker said Mehmet Oz knows firsthand the impact of medical technologies on disease prevention and treatment. Oz holds a patent on Abbott’s Mitraclip heart device.
|
The partnership will support data flows that enable people who use both companies’ devices to track how glucose levels affect other health metrics.
|
How do you get your medical device past complex trial obstacles and over the finish line? Explore the the tools and strategic planning that can help reduce costs and delays in this playbook.
|
|
From Our Library
Webinar - on demand
Custom content for Avery Dennison
|
Webinar - on demand
Custom content for ORO Labs
|
Survey Report
Custom content for AcuityMD
|
|